Italia markets closed

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
275,94+0,34 (+0,12%)
Alla chiusura: 04:00PM EDT
276,89 +0,95 (+0,34%)
Dopo ore: 05:59PM EDT

Bio-Rad Laboratories, Inc.

1000 Alfred Nobel Drive
Hercules, CA 94547
United States
510 724 7000
https://www.bio-rad.com

Settore/iHealthcare
SettoreMedical Devices
Impiegati a tempo pieno8.030

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Norman D. SchwartzChairman, CEO & President1,25M19,51M1950
Dr. Andrew J. Last Ph.D.Executive VP & COO682,29kN/D1960
Dr. Simon MayExecutive VP & President of the Life Science Group536,25kN/D1972
Mr. Roop K. LakkarajuExecutive VP & CFON/DN/D1971
Ms. Tania DeVilliersSenior Director, Corporate Controller & Interim Principal Accounting OfficerN/DN/D1974
Mr. Yong ChungVice President of Investor RelationsN/DN/DN/D
Mr. Timothy S. ErnstExecutive VP, General Counsel & SecretaryN/DN/D1960
Matthew WernerSenior Vice President and Chief Compliance & Privacy OfficerN/DN/DN/D
Ms. Colleen CoreyExecutive Vice President of Global Human ResourcesN/DN/D1962
Mr. Michael CrowleyExecutive Vice President of Global Commercial Operations974,94k1,85M1962
Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Governance aziendale

L'ISS Governance QualityScore di Bio-Rad Laboratories, Inc. al 1 aprile 2024 è 10. I criteri di valutazione fondamentali sono revisione: 10; Consiglio di Amministrazione: 10; diritti degli azionisti: 10; retribuzione: 8.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.